A Bruton's Tyrosine Kinase Inhibitor Prevents Antigen-Driven B Cell Activation In Vivo

被引：0
|
作者：
Benson, Micah [1 ]
Rodriguez, Varenka A. [1 ]
Andreyeva, Tatyana [1 ]
Keegan, Sean [1 ]
Springer, John R. [1 ]
Schnute, Mark E. [1 ]
Dunussi-Joannopoulos, Kyri [1 ]
Nickerson-Nutter, Cheryl L. [1 ]
Rankin, Andrew L. [1 ]
Ruzek, Melanie [1 ]
Douhan, John, III [1 ]
机构：
[1] Pfizer Inc, Cambridge, MA USA
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1758
引用
收藏
页码：S689 / S689
页数：1
相关论文
共 50 条
  • [1] A Bruton's Tyrosine Kinase inhibitor prevents antigen-driven B cell activation, germinal center persistence and memory B cell re-activation in vivo
    Rodriguez, Varenka
    Springer, John
    Schnute, Mark
    Dunussi-Joannopoulos, Kyri
    Douhan, John
    Ruzek, Melanie
    Benson, Micah
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [2] Inhibition Of Bruton's Tyrosine Kinase Selectively Prevents Antigen Activation Of B Cells And Ameliorates B-Cell-Mediated Experimental Autoimmune Encephalomyelitis
    Torke, S.
    Pretzsch, R.
    Haeusler, D.
    Grenningloh, R.
    Boschert, U.
    Brueck, W.
    Weber, M. S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 60 - 61
  • [3] Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Aht
    Craxton, A
    Jiang, AM
    Kurosaki, T
    Clark, EA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) : 30644 - 30650
  • [4] Development of the Bruton's tyrosine kinase inhibitor ibrutinib for B cell malignancies
    Gayko, Urte
    Fung, Mann
    Clow, Fong
    Sun, Steven
    Faust, Elizabeth
    Price, Samiyeh
    James, Danelle
    Doyle, Margaret
    Bari, Samina
    Zhuang, Sen Hong
    PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN 2014, 2015, 1358 : 82 - 94
  • [5] Lysine Acetylation Regulates Bruton's Tyrosine Kinase in B Cell Activation
    Liu, Zhijian
    Mai, Antonello
    Sun, Jian
    JOURNAL OF IMMUNOLOGY, 2010, 184 (01): : 244 - 254
  • [6] Molecular requirements for antigen-driven B cell activation
    Ferapontov, A.
    Omer, M.
    Baudrexel, I.
    Nielsen, J.
    Dupont, D.
    Juul--Madsen, K.
    Thiel, S.
    Vorup-Jensen, T.
    Jungmann, R.
    Kjems, J.
    Degn, S.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2021, 94 (06)
  • [7] Inhibition of Bruton's tyrosine kinase selectively prevents antigen-activation of B cells and ameliorates B cell-mediated experimental autoimmune encephalomyelitis
    Torke, S.
    Haeusler, D.
    Grenningloh, R.
    Boschert, U.
    Brueck, W.
    Weber, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 513 - 514
  • [8] Inhibition of Bruton's tyrosine kinase selectively prevents antigen-activation of B cells and ameliorates B cell-mediated experimental autoimmune encephalomyelitis
    Torke, S.
    Greeningloh, R.
    Boschert, U.
    Weber, M.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 276 - 276
  • [9] Inhibition of Bruton's Tyrosine Kinase Selectively Prevents Antigen-Activation B cells and Ameliorates B-Cell-Mediated Experimental Autoimmune Encephalomyelitis
    Torke, Sebastian
    Grenningloh, Roland
    Brueck, Wolfgang
    Boschert, Ursula
    Weber, Martin
    NEUROLOGY, 2019, 92 (15)
  • [10] Transphosphorylation of Bruton's tyrosine kinase on tyrosine 551 is critical for B cell antigen receptor function
    Kurosaki, T
    Kurosaki, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (25) : 15595 - 15598
12345